PROBI AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 207 SEK | -6.33% |
|
-4.17% | +1.97% |
| Mar. 13 | Probi AB Strengthens Its Brand Position and Expands in the Nordics | CI |
| Jan. 26 | Transcript : Probi AB, Q4 2023 Earnings Call, Jan 26, 2024 |
Presentation Operator MessageOperator (Operator)Good morning, and welcome to the Probi Q2 2022...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Companyâs activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Sector
Pharmaceuticals
Calendar
2024-04-23
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.97% | 231M | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
- Stock Market
- Equities
- PROB Stock
- News Probi AB
- Transcript : Probi AB, Q2 2022 Earnings Call, Jul 15, 2022
